Literature DB >> 24776487

Targeting and activation of antigen-specific B-cells by calcium phosphate nanoparticles loaded with protein antigen.

Vladimir V Temchura1, Diana Kozlova2, Viktoriya Sokolova2, Klaus Uberla3, Matthias Epple2.   

Abstract

Cross-linking of the B-cell receptors of an antigen-specific B-cell is the initial signal for B-cell activation, proliferation, and differentiation into antibody secreting plasma cells. Since multivalent particulate structures are efficient activators of antigen-specific B-cells, we developed biodegradable calcium phosphate nanoparticles displaying protein antigens on their surface and explored the efficacy of the B-cell activation after exposure to these nanoparticles. The calcium phosphate nanoparticles were functionalized with the model antigen Hen Egg Lysozyme (HEL) to take advantage of a HEL-specific B-cell receptor transgenic mouse model. The nanoparticles were characterized by scanning electron microscopy and dynamic light scattering. The functionalized calcium phosphate nanoparticles were preferentially bound and internalized by HEL-specific B-cells. Co-cultivation of HEL-specific B-cells with the functionalized nanoparticles also increased surface expression of B-cell activation markers. Functionalized nanoparticles were able to effectively cross-link B-cell receptors at the surface of antigen-matched B-cells and were 100-fold more efficient in the activation of B-cells than soluble HEL. Thus, calcium phosphate nanoparticles coated with protein antigens are promising vaccine candidates for induction humoral immunity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B-cell activation; Calcium phosphate; Cell targeting; Nanoparticles

Mesh:

Substances:

Year:  2014        PMID: 24776487     DOI: 10.1016/j.biomaterials.2014.04.010

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

1.  'Bio-nano interactions: new tools, insights and impacts': summary of the Royal Society discussion meeting.

Authors:  Iseult Lynch; Ilise L Feitshans; Michaela Kendall
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

Review 2.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

Review 3.  The application of nanotechnology in enhancing immunotherapy for cancer treatment: current effects and perspective.

Authors:  Yongjiang Li; Ciceron Ayala-Orozco; Pradipta Ranjan Rauta; Sunil Krishnan
Journal:  Nanoscale       Date:  2019-09-18       Impact factor: 7.790

Review 4.  Beyond antigens and adjuvants: formulating future vaccines.

Authors:  Tyson J Moyer; Andrew C Zmolek; Darrell J Irvine
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 5.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

Review 6.  Strategies to guide the antibody affinity maturation process.

Authors:  Nicole A Doria-Rose; M Gordon Joyce
Journal:  Curr Opin Virol       Date:  2015-04-24       Impact factor: 7.090

Review 7.  Polymeric micro- and nanoparticles for immune modulation.

Authors:  Elana Ben-Akiva; Savannah Est Witte; Randall A Meyer; Kelly R Rhodes; Jordan J Green
Journal:  Biomater Sci       Date:  2018-12-18       Impact factor: 6.843

Review 8.  Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications.

Authors:  Yueh-Hsia Luo; Louis W Chang; Pinpin Lin
Journal:  Biomed Res Int       Date:  2015-06-01       Impact factor: 3.411

Review 9.  Engineering nanoparticles to overcome barriers to immunotherapy.

Authors:  Randall Toy; Krishnendu Roy
Journal:  Bioeng Transl Med       Date:  2016-06-20

Review 10.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.